The Melanoma Research Alliance (MRA) recently announced the awarding of over $10.5 million for 18 research projects that are being led by investigators at 30 institutions in seven countries. These projects will accelerate new therapeutic approaches for melanoma, improve existing treatments, develop new biomarkers, and advance the understanding of melanoma risk factors.
"Our efforts in MRA's relatively short existence have helped accelerate the pace of new discoveries to treat and prolong life for patients with this vicious cancer. Through our scientific program, MRA has attracted hundreds of new researchers to the cause of finding treatments and ultimately, we hope, cures for melanoma," says Debra Black, chair and co-founder of MRA.
Want to read more?
Subscribe to one of our monthly plans to continue reading this article.